Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,312,155
Closed -$151M 6527
2026
Q1
$151M Buy
1,312,155
+643,675
+96% +$56.8M 0.02% 820
2025
Q4
$43.6M Buy
668,480
+220,039
+49% +$17.6M 0.01% 1622
2025
Q3
$36.8M Sell
448,441
-62,164
-12% -$4.48M ﹤0.01% 1680
2025
Q2
$33.6M Buy
510,605
+335,817
+192% +$20.9M ﹤0.01% 1651
2025
Q1
$11.5M Sell
174,788
-115,223
-40% -$7.81M ﹤0.01% 2561
2024
Q4
$22.2M Sell
290,011
-9,248
-3% -$799K ﹤0.01% 2023
2024
Q3
$25M Buy
299,259
+41,092
+16% +$2.74M ﹤0.01% 1853
2024
Q2
$14.2M Sell
258,167
-14,626
-5% -$795K ﹤0.01% 2171
2024
Q1
$19M Sell
272,793
-82,900
-23% -$5.26M ﹤0.01% 1884
2023
Q4
$19.7M Sell
355,693
-519,165
-59% -$23.4M ﹤0.01% 1898
2023
Q3
$31.4M Sell
874,858
-144,056
-14% -$4.97M 0.01% 1419
2023
Q2
$32.2M Sell
1,018,914
-251,812
-20% -$9.63M 0.01% 1441
2023
Q1
$39.2M Buy
1,270,726
+1,148,609
+941% +$34.8M 0.01% 1242
2022
Q4
$3.78M Buy
122,117
+33,938
+38% +$778K ﹤0.01% 3422
2022
Q3
$1.66M Buy
+88,179
New +$1.69M ﹤0.01% 4126
2022
Q2
Sell
-58,059
Closed -$814K 6421
2022
Q1
$814K Buy
+58,059
New +$971K ﹤0.01% 4990

Other funds holding ACLX

Goldman Sachs's ACLX Position: Q2 2026 in Review

Goldman Sachs sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 1,312,155 shares — an estimated $151M sold.

Goldman Sachs first reported a position in ACLX in Q1 2022 and held it in 16 quarters. The position peaked at $151M in Q1 2026. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

  • Goldman Sachs reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 1,312,155 Arcellx shares in Q2 2026, an estimated $151M.
  • Goldman Sachs first reported a position in Arcellx in Q1 2022 and held it in 16 quarters.
  • Goldman Sachs's Arcellx position peaked at $151M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.